COMMUNIQUÉS West-GlobeNewswire

Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
31/10/2017
PRESS RELEASE Immunocore to Present New Overall Survival Data in Metastatic Uveal Melanoma at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting (Oxford, UK and Conshohocken, US, 31 October 2017) [...]
Verona Pharma to Present at Two Upcoming Investor Conferences
31/10/2017
LONDON, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
DBV Technologies Reports September 30, 2017 Cash Position
31/10/2017
Press Release Montrouge, France, October 31, 2017 DBV Technologies Reports September 30, 2017 Cash Position DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) today announced its cash and [...]
DBV Technologies publie sa position de trésorerie au 30 septembre 2017
31/10/2017
Communiqué de Presse Montrouge, France, le 31 octobre 2017, 7h30 CET DBV Technologies publie sa position de trésorerie au 30 septembre 2017 DBV Technologies, (Euronext: DBV - ISIN : FR0010417345 - NASDAQ : DBVT), [...]
Basilea's Chief Medical Officer Prof. Achim Kaufhold to retire and Dr. Marc Engelhardt named as successor
31/10/2017
Basel, Switzerland, October 31, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reported today that Prof. Achim Kaufhold will retire after seven years with the company. Basilea named Dr. Marc Engelhardt, currently Basilea [...]
Novartis submits application to FDA for KymriahTM (tisagenlecleucel) in adult patients with r/r DLBCL, seeking second indication for first-ever FDA approved CAR-T therapy
31/10/2017
Media release (PDF) This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the [...]
Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
31/10/2017
ALLSCHWIL/BASEL, SWITZERLAND - October 31, 2017 - By decision dated October 25, 2017, the Cantonal Court of the Canton of Basel-Landschaft cancelled all publicly held registered shares of Actelion Ltd ( Actelion ) with [...]
TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure
31/10/2017
PRESS RELEASE TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure Leuven (BELGIUM) - October 31, 2017, 7:00h CET - TiGenix NV (Euronext Brussels and NASDAQ: TIG), an advanced [...]
ABLYNX CLOSES ON UNDERWRITERS' OPTION TO PURCHASE $30 MILLION OF ADDITIONAL SHARES IN THE U.S. INITIAL PUBLIC OFFERING
30/10/2017
REGULATED INFORMATION GHENT, Belgium, 30 October 2017 - Ablynx NV [Euronext Brussels and Nasdaq: ABLX] , a late-stage clinical biopharmaceutical company utilising its proprietary Nanobody® platform to develop treatments [...]
Nightstar Therapeutics to Participate in Multiple Conferences in November
30/10/2017
LEXINGTON, Mass. and LONDON, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Nightstar Therapeutics plc (NASDAQ:NITE), a clinical-stage gene therapy company developing treatments for rare inherited retinal diseases, today announced [...]
Diaxonhit : Résultats semestriels 2017, Bénéfices très positifs de l'acquisition de Capforce Plus
30/10/2017
DIAXONHIT - Résultats semestriels 2017 Premiers bénéfices très positifs de l'acquisition de Capforce Plus Réussite de la première phase d'intégration Accélération de la dynamique commerciale Objectifs opérationnels [...]
Exercise of over-allotment option in relation to the IPO of Terveystalo Plc and termination of the stabilization period
30/10/2017
TERVEYSTALO PLC STOCK EXCHANGE RELEASE 30 October, 2017 at 19:00 EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, THE HONG KONG SPECIAL [...]
NANOBIOTIX lance une augmentation de capital par construction accelerée d'un livre d'ordre
30/10/2017
NANOBIOTIX LANCE UNE AUGMENTATION DE CAPITAL PAR CONSTRUCTION ACCELEREE D'UN LIVRE D'ORDRE Paris, France, et Cambridge, Massachusetts, USA, 30 octobre 2017 - NANOBIOTIX (la « Société ») (Euronext: NANO - ISIN: [...]
NANOBIOTIX launches capital increase by means of an accelerated bookbuild offering
30/10/2017
NANOBIOTIX LAUNCHES CAPITAL INCREASE BY MEANS OF AN ACCELERATED BOOKBUILD OFFERING Paris, France and Cambridge, Massachusetts, October 30, 2017 - NANOBIOTIX (the " Company ") (Euronext: NANO - ISIN: FR0011341205), a [...]
Ascom wins order to supply advanced nurse call solution for elderly care facilities in Norway
30/10/2017
BAAR, Switzerland, Oct. 30, 2017 (GLOBE NEWSWIRE) -- Ascom (SWX:ASCN.SW) secures a long term contract with the Drammen municipality in Norway to modernize and improve the communication infrastructure of its elderly care [...]
Ossur Hf : Transactions in relation to share buyback program
30/10/2017
Announcement from Össur hf. No. 79/2017 Reykjavík, 30 October 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]
Ossur Hf: Insider trading
30/10/2017
Announcement Össur hf. N o. 78/2017 Viðskipti með eigin bréf/ transaction in own financial instruments Nafn/Name: Össur hf. Dagsetning viðskipta/Date of transaction: 30 October 2017 Kaup eða sala/Buy or Sell: Sell [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
30/10/2017
FIT Biotech Oy Company release October 30, 2017 at 4:00 pm FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On September 26, 2016, the Board of Directors of FIT Biotech Oy ( [...]
Vascular Dynamics Interim Data on MobiusHD Presented at TCT Conference Shows Significant Reductions in Ambulatory Systolic Blood Pressure At Six Months
30/10/2017
Company Has Initiated Pivotal Trial for the MobiusHD in the US and EU MOUNTAIN VIEW, Calif., Oct. 30, 2017 (GLOBE NEWSWIRE) -- Vascular Dynamics, Inc., a privately held medical device company developing novel solutions [...]

Pages